Evidence-Based Medicine Guidelines
Comparison of HMG-CoA reductase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Comparison of HMG-CoA Reductase Inhibitors." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455152/all/Comparison_of_HMG_CoA_reductase_inhibitors.
Comparison of HMG-CoA reductase inhibitors. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455152/all/Comparison_of_HMG_CoA_reductase_inhibitors. Accessed April 23, 2024.
Comparison of HMG-CoA reductase inhibitors. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455152/all/Comparison_of_HMG_CoA_reductase_inhibitors
Comparison of HMG-CoA Reductase Inhibitors [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455152/all/Comparison_of_HMG_CoA_reductase_inhibitors.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Comparison of HMG-CoA reductase inhibitors
ID - 455152
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455152/all/Comparison_of_HMG_CoA_reductase_inhibitors
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
